AEI Clients in the COVID-19 Fight: NIH, Amgen, Takeda
New public-private network to speed pandemic response.
The National Institutes of Health (NIH) and the Foundation for the NIH have announced that they are assembling a government and industry partnership to identify, prioritize, and facilitate the most promising COVID-19 vaccine and drug candidates into clinical trials.
To date, the group includes 16 leading biopharmaceutical companies, the CDC, the USFDA, the European Medicines Agency, and others.